Healthcare Industry News:  Cardinal Health 

Biopharmaceuticals Personnel

 News Release - January 18, 2007

Alpharma Names Executive Vice President, Human Resources and Communication

FORT LEE, N.J., Jan. 18 (HSMN NewsFeed) -- Alpharma Inc. (NYSE: ALO ), a leading global specialty pharmaceutical company announced today that Peter M. Watts has joined the company as Executive Vice President, Human Resources and Communications reporting directly to Dean Mitchell, President and Chief Executive Officer. Mr. Watts has over 20 years of experience in U.S. and International human resources management and consulting, including key roles at Novartis and Warner-Lambert. Prior to joining Alpharma, Mr. Watts was the Senior Vice President, Human Resources and Employee Services at Scholastic Corporation.

"I am pleased to add a human resources executive of Peter's talent and experience to the Alpharma management team," commented Dean Mitchell, President and Chief Executive Officer. "In order to achieve the ambitious growth objectives the company is targeting, a top company priority is to attract, retain and develop the best talent available. I am confident that Peter's skill, energy, and vision will result in the creation of a team well equipped to execute the company's growth initiatives."

Prior to his role at Scholastic, Mr. Watts held several key human resources positions in the pharmaceutical industry, including Vice President, Human Resources, for the U.S. Pharmaceutical business of Novartis and Vice President, Human Resources - Europe, at Warner-Lambert. His consulting experience included clients such as Warner-Chilcott, Cardinal Health, Oak Hill Capital, and Bank of America.

Mr. Watts is a graduate of Cornell University in Industrial and Labor Relations and earned an MBA with honors from Columbia Business School.

Alpharma press releases are also available at our website: http://www.alpharma.com.

Alpharma Inc. (NYSE: ALO ) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIANĀ® product. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.


Source: Alpharma

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.